Cytosorbents CTSO
NASDAQ CTSO
$0.34 -0.01 (-3.63%)
At close: Aug 20, 2026 · 1:07 PM UTC

Cytosorbents (CTSO) Asset Writedowns and Impairment (2016 - 2026)

Cytosorbents' (CTSO) quarterly Asset Writedowns and Impairment came in at $300000.0 in Q1 2026, up 1204.35% on a QoQ basis from $23000.0 in Q4 2025.

Cytosorbents (CTSO) Asset Writedowns and Impairment (2016 - 2026) Analysis & Trends

Cytosorbents (CTSO) has 11 years of Asset Writedowns and Impairment data on file, last reported at $300000.0 in Q1 2026.

  • Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $300000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $340000.0 (up 296.46% YoY) and the FY2025 annual result came in at $40000.0, down 65.22% from the prior year.
  • Asset Writedowns and Impairment advanced to $300000.0 in Q1 2026, from $23000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $462237.0 in Q3 2023 to a low of -$461187.0 in Q4 2023.
  • A 5-year average of $69065.0 and a median of $20209.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
  • Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment surged 6533.08% — and 2023, when it slumped 661.72%.
  • Tracing CTSO's Asset Writedowns and Impairment over 5 years: stood at $204180.0 in 2022, then tumbled by 325.87% to -$461187.0 in 2023, then soared by 101.73% to $8000.0 in 2024, then jumped by 187.5% to $23000.0 in 2025, then jumped by 1204.35% to $300000.0 in 2026.
  • The last three Asset Writedowns and Impairment figures came in at $300000.0 (Q1 2026), $23000.0 (Q4 2025), and $8000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn
10 Cytosorbents 21.57 Mn 17.16 Mn 7.05 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 38,000.00
Jun 30, 2026 38,000.00
Mar 31, 2026 300,000.00
Mar 31, 2026 300,000.00
Dec 31, 2025 23,000.00
Dec 31, 2025 23,000.00
Sep 30, 2025 8,000.00
Sep 30, 2025 8,000.00
Jun 30, 2025 9,000.00
Jun 30, 2025 9,000.00
Dec 31, 2024 8,000.00
Dec 31, 2024 8,000.00
Sep 30, 2024 78,000.00
Sep 30, 2024 78,000.00
Jun 30, 2024 -240.00
Jun 30, 2024 -240.00
Mar 31, 2024 29,240.00
Mar 31, 2024 29,240.00
Dec 31, 2023 -461,187.00
Dec 31, 2023 -461,187.00